40
Participants
Start Date
December 31, 2011
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
warfarin
Warfarin in anticoagulant dose
Bemiparina
"Group 2 (VKA oral anticoagulation: warfarin), which is the control group will receive VKA anticoagulation as before they had the bleeding episode, with regular monitoring by measurement of prothrombin time (INR). Patients taking acenocoumarol before bleeding episode will be treated with warfarin and the once who were receiving warfarin will continue with the same treatment. Treatment control is performed by measuring the INR periodically.~Randomization will be performed using sealed opaque envelopes that contain the treatment option that will be obtained through a list of random numbers generated by computer."
Hospital de la Santa Creu i Sant Pau, Barcelona
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
OTHER